Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study

PURPOSE: There is growing interest in low-dose metronomic chemotherapy (LDMC) in metastatic breast cancer (MBC). In this retrospective case–control analysis, we compared the efficacy of LDMC and conventional chemotherapy (CCT) in MBC. METHODS: Each LDMC patient receiving oral cyclophosphamide (CTX)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res Treat
Autori principali: Krajnak, S., Schnatz, C., Almstedt, K., Brenner, W., Haertner, F., Heimes, A.-S., Lebrecht, A., Makris, G.-M., Schwab, R., Hasenburg, A., Schmidt, M., Battista, M. J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2020
Soggetti:
Clinical Trial
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297707/
https://ncbi.nlm.nih.gov/pubmed/32495001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05711-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi